Daniel Canals (D Canals)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Molecular pharmacology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Journal of lipid research

Oncogene

Stony Brook University Health Sciences Center School of Medicine

Universitat Autonoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stony Brook University Health Sciences Center School of Medicine Feb 01 2015

United States

Assistant Professor of Research Medicine :: Medicine

Education History

Universitat Autonoma de Barcelona

Spain

PHD :: Biochemistry and Molecular Biology

Publications

Maria Hernandez-Corbacho, Daniel Canals
Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways. Molecular pharmacology 105 (3) (2024)
Maria Hernandez-Corbacho, Daniel Canals
Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways. Molecular pharmacology 105 (3) (2024)
Maria Hernandez-Corbacho, Daniel Canals
Drug targeting of acyltransferases in the Triacylglyceride and 1-O-AcylCeramide biosynthetic pathways. Molecular pharmacology (2023)
Sarah Alsamman, Stephanie A Christenson, Amy Yu, Nadia M E Ayad, Meghan S Mooring, Joe M Segal, Jimmy Kuang-Hsien Hu, Johanna R Schaub, Steve S Ho, Vikram Rao, Megan M Marlow, Scott M Turner, Mai Sedki, Lorena Pantano, Sarani Ghoshal, Diego Dos Santos Ferreira, Hsiao-Yen Ma, Caroline C Duwaerts, Regina Espanol-Suner, Lan Wei, Benjamin Newcomb, Izolda Mileva, Daniel Canals, Yusuf A Hannun, Raymond T Chung, Aras N Mattis, Bryan C Fuchs, Andrew M Tager, Dean Yimlamai, Valerie M Weaver, Alan C Mullen, Dean Sheppard, Jennifer Y Chen
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice. Science translational medicine 12 (557) (2021)
Xuewei Zhang, Wataru Sakamoto, Daniel Canals, Masumi Ishibashi, Masaya Matsuda, Kentaro Nishida, Masafumi Toyoshima, Shogo Shigeta, Makoto Taniguchi, Can E Senkal, Toshiro Okazaki, Nobuo Yaegashi, Yusuf A Hannun, Takeshi Nabe, Kazuyuki Kitatani
Ceramide synthase 2-C24:1 -ceramide axis limits the metastatic potential of ovarian cancer cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (2) (2021)
Daniel Canals, Silvia Salamone, Bruno Jaime Santacreu, Daniel Aguilar, María José Hernandez-Corbacho, Anne G Ostermeyer-Fay, Meaghan Greene, Erika Nemeth, John D Haley, Lina M Obeid, Yusuf A Hannun
The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (3) (2021)
Wataru Sakamoto, Daniel Canals, Silvia Salamone, Janet Allopenna, Christopher J Clarke, Justin Snider, Lina M Obeid, Yusuf A Hannun
Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases. Journal of lipid research 60 (11) (2019)
Wataru Sakamoto, Nicolas Coant, Daniel Canals, Lina M Obeid, Yusuf A Hannun
Functions of neutral ceramidase in the Golgi apparatus. Journal of lipid research 59 (11) (2018)
M Wada, Daniel Canals, M Adada, N Coant, M F Salama, K L Helke, J S Arthur, K R Shroyer, Kazuyuki Kitatani, L M Obeid, Y A Hannun
P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene 36 (47) (2017)

Daniel Canals.css-eqlu8i{font-size:small;padding-left:4px;} (D Canals)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Canals (D Canals)